1. The role of microRNAs in prethrombotic status associated with coronary artery disease
   Jie Gao et al, 2017, Thrombosis and Haemostasis CrossRef
2. Interleukin-6 and microRNA profiles induced by oral bacteria in human atheroma derived and healthy smooth muscle cells
   Tanja Pessi et al, 2015, SpringerPlus CrossRef
3. MicroRNA‐181 in cardiovascular disease: Emerging biomarkers and therapeutic targets
   Bingjie Lv et al, 2024, The FASEB Journal CrossRef
4. Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy
   Luisa F. Gomez-Arango et al, 2016, Hypertension CrossRef
5. The diagnostic value and regulatory mechanism of miR-200a targeting ZEB1 in pregnancy-induced hypertension
   Gui-Mei Wu et al, 2020, Hypertension in Pregnancy CrossRef
6. Role of microRNAs in sepsis
   S. Manoj Kumar Kingsley et al, 2017, Inflammation Research CrossRef
7. The effects of sepsis on endothelium and clinical implications
   Elena V Dolmatova et al, 2021, Cardiovascular Research CrossRef
8. Research Progress on the Role and Mechanism of Short Chain Fatty Acidsin Hypertensive Disorders of Pregnancy
   晶晶 李, 2022, Advances in Clinical Medicine CrossRef
9. Plasminogen Activator Inhibitor Type‐1 as a Regulator of Fibrosis
   Reyhaneh Rabieian et al, 2018, Journal of Cellular Biochemistry CrossRef
10. Preeclamptic Women Have Disrupted Placental microRNA Expression at the Time of Preeclampsia Diagnosis: Meta-Analysis
    Andja Cirkovic et al, 2021, Frontiers in Bioengineering and Biotechnology CrossRef
11. Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy
    Maciej Ziętek et al, 2021, Nutrients CrossRef
12. In vitro effects of sEng and TGF‐β on human umbilical vein endothelial cells and trophoblasts
    Ketao Wang et al, 2018, Journal of Obstetrics and Gynaecology Research CrossRef
13. Role and new insights of microfibrillar‐associated protein 4 in fibrotic diseases
    Long Zhu et al, 2024, APMIS CrossRef